United States · FDA National Drug Code directory
COPIKTRA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 73116-215_30ff13f0-1e77-43de-99c9-c309834f1e63
- Product NDC
- 73116-215
- Form
- CAPSULE
- Composition / generic term
- duvelisib
- Labeler
- Secura Bio, Inc
- Marketing category
- NDA
- Marketing start / end (source format)
- 20180925
- Source listing expiry
- 20261231
Source-listed ingredients
- DUVELISIB — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 28 CAPSULE in 1 PACKAGE (73116-215-28) · 73116-215-28
- 56 CAPSULE in 1 PACKAGE (73116-215-56) · 73116-215-56
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →